USA External Ventricular Drain Market Outlook to 2028

USA External Ventricular Drain Market Overview

The USA External Ventricular Drain (EVD) market was valued at USD 1.6 billion. This market is primarily driven by the rising incidence of neurological disorders such as hydrocephalus, traumatic brain injuries, and strokes. The growing aging population and increasing demand for advanced neurosurgical interventions in the U.S. healthcare system are significant contributors to market growth.

The market, with cities such as New York, Los Angeles, and Chicago leading the way. These regions are home to top-tier healthcare institutions, including specialized neurosurgical centers, driving higher adoption of EVD systems. The dominance of these cities can be attributed to the availability of skilled neurosurgeons, advanced healthcare infrastructure, and investments in healthcare technology, positioning the U.S. as a global leader in neurological care.

The U.S. government's continued expansion of Medicare and Medicaid programs, which now covers over 82 million people in 2024, has increased access to healthcare services, including critical neurological procedures that involve the use of EVDs.

USA External Ventricular Drain Market Segmentation

By Product Type: The market is segmented by product type into Disposable EVD Systems and Reusable EVD Systems. Disposable EVD Systems have a dominant market share due to their increasing adoption in hospitals and surgical centers. This dominance stems from the convenience and reduced risk of infections associated with disposable systems. Healthcare facilities are prioritizing disposable systems to prevent hospital-acquired infections, improve patient outcomes, and comply with stringent FDA and CDC guidelines regarding infection control.

By Application: The market is also segmented by application into Trauma & Emergency Care, Cerebral Aneurysms, Stroke Management, and Hydrocephalus Treatment. Hydrocephalus Treatment leads this segmentation, with a significant market share. Hydrocephalus, which is prevalent among both pediatric and geriatric populations, drives the demand for EVD systems. Early diagnosis and the rise of minimally invasive neurosurgical techniques have contributed to this segment's growth, supported by increased healthcare funding and advanced medical devices tailored for treating hydrocephalus.

USA External Ventricular Drain Market Competitive Landscape

The market is consolidated, with a few key players controlling significant market shares. Companies like Medtronic PLC and Integra Lifesciences Holdings Corporation lead the market due to their robust product portfolios, continuous product innovations, and strong distribution networks. These companies have made substantial investments in research and development to introduce next-generation EVD systems, further driving market growth.

Company

Established Year

Headquarters

No. of Patents Filed

R&D Expenditure (%)

Market Share (%)

Key Product Portfolio

Partnerships/Collaborations

FDA Approvals

Medtronic PLC

1949

Dublin, Ireland

Integra Lifesciences Holdings Corp

1989

Princeton, NJ, USA

B. Braun Melsungen AG

1839

Melsungen, Germany

Johnson & Johnson (De Puy Synthes)

1886

New Brunswick, NJ, USA

Sophysa

1976

Orsay, France

USA External Ventricular Drain Market Analysis

Market Growth Drivers

Increasing Prevalence of Neurological Disorders: The USA has witnessed a rise in neurological disorders, particularly traumatic brain injuries (TBIs), which is a major factor driving the demand for external ventricular drains (EVDs). In 2024, the CDC reported over 2.8 million annual emergency department visits due to TBI-related complications, leading to an increased requirement for EVD procedures to manage intracranial pressure.

Government Healthcare Spending: U.S. government expenditure on healthcare continues to rise, with the Congressional Budget Office estimating federal health care spending to exceed $1.4 trillion in 2024. This increase in funding for hospitals and medical centers is anticipated to facilitate the procurement and use of EVDs in more medical facilities across the country.

Increasing Number of Neurosurgeries: The increasing availability of specialized neurosurgical centers in the USA has driven up the number of brain surgeries, many of which require EVDs for postoperative care. According to the American Association of Neurological Surgeons, around 100,000 hydrocephalus-related surgeries occur annually in the USA, many of which involve EVD placement.

Market Challenges

Regulatory Approval Delays: The U.S. FDAs stringent regulations on medical devices have led to delays in the approval and adoption of newer, advanced EVD technologies. In 2024, manufacturers faced an average delay of 18-24 months for the approval of EVD-related products, impacting market growth.

Risk of EVD-Associated Infections: One of the major challenges in the EVD market is the risk of device-associated infections. Studies from 2024 show that about 10,000 nosocomial infections occur annually in the U.S., leading to extended hospital stays and additional healthcare costs, raising concerns about widespread EVD usage.

USA External Ventricular Drain Market Future Outlook

Over the next five years, the USA External Ventricular Drain industry is expected to experience sustained growth driven by continuous advancements in EVD technology, such as the development of antimicrobial and infection-resistant materials. The market's expansion will also be fueled by rising demand for neurosurgical interventions due to the growing elderly population and the increased prevalence of conditions like hydrocephalus and traumatic brain injuries.

Future Market Opportunities

Rise in Demand for Minimally Invasive EVD Systems: Over the next five years, the demand for minimally invasive EVD systems is expected to grow in the U.S. market, driven by the push for shorter recovery times and reduced infection risks. Leading manufacturers will likely develop systems with enhanced biocompatibility and infection control measures.

Increased Adoption of Telemonitoring in EVD Systems: By 2029, telemonitoring capabilities in EVD systems will become more commonplace in the U.S. healthcare system. This trend will allow neurosurgeons to remotely monitor patient conditions, reducing the need for extended hospital stays and improving patient outcomes.
Please Note: It will take 5-7 business days to complete the report upon order confirmation